In Vivo efficacy assessment of the CDK4/6 inhibitor palbociclib and the PLK1 inhibitor volasertib in Human Chordoma Xenografts [Target-seq]
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Analysis of gene mutations and copy number variation status by an in-house next-generation sequencing (NGS) panel. The panel includes 571 genes of interest in oncology for diagnosis, prognosis, and theranostics including chordomas genes of interest. Three chordoma Patient’s Derived Xenograft (PDX) models (CD3, CD7 and CD39) and corresponding germline samples were analyzed.
创建时间：
2023-01-04
